Regencell Bioscience Holdings Limited (NASDAQ:RGC - Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $52.88, but opened at $62.00. Regencell Bioscience shares last traded at $37.40, with a volume of 1,740,340 shares traded.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a "sell (e+)" rating on shares of Regencell Bioscience in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of "Sell".
Check Out Our Latest Report on Regencell Bioscience
Regencell Bioscience Price Performance
The company's 50 day moving average is $17.39 and its 200 day moving average is $16.15.
Hedge Funds Weigh In On Regencell Bioscience
A number of institutional investors and hedge funds have recently modified their holdings of RGC. Greenfield Savings Bank bought a new stake in Regencell Bioscience during the second quarter worth $187,000. Y Intercept Hong Kong Ltd purchased a new position in Regencell Bioscience during the 2nd quarter worth $222,000. XTX Topco Ltd bought a new stake in shares of Regencell Bioscience in the 3rd quarter worth $598,000. BNP Paribas Financial Markets purchased a new stake in shares of Regencell Bioscience in the second quarter valued at about $768,000. Finally, Squarepoint Ops LLC bought a new position in shares of Regencell Bioscience during the second quarter valued at about $1,701,000. 0.13% of the stock is currently owned by institutional investors.
About Regencell Bioscience
(
Get Free Report)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Regencell Bioscience, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Regencell Bioscience wasn't on the list.
While Regencell Bioscience currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
